Table 1.
No Impairment | Mild Impairment | Severe Impairment | |
---|---|---|---|
N | 338 (93.4%) | 12 (3.3%) | 12 (3.3%) |
Recipient Characteristics1 | |||
Female | 150 (44.4%) | 4 (33.3%) | 9 (75.0%) |
Black | 65 (19.2%) | 1 (8.3%) | 2 (16.7%) |
Hispanic | 7 (2.1%) | 0 (0.0%) | 1 (8.3%) |
Age | 49.0 (36.0–59.0) | 50.0 (30.0–60.0) | 33.5 (23.5–43.0) |
Years on Dialysis | 0.7 (0.0–2.4) | 0.4 (0.0–2.0) | 0.5 (0.0–1.9) |
BMI | 27.1 (23.0–30.9) | 24.3 (22.2–28.3) | 22.6 (22.0–24.4) |
HCV | 3 (0.9%) | 0 (0.0%) | 1 (8.3%) |
College Educated | 251 (76.1%) | 7 (58.3%) | 8 (72.7%) |
Employed | 204 (60.7%) | 4 (33.3%) | 6 (54.5%) |
Public Insurance | 123 (36.4%) | 4 (33.3%) | 3 (25.0%) |
Diabetes | 43 (12.7%) | 2 (16.7%) | 0 (0.0%) |
Hypertension | 63 (18.6%) | 3 (25.0%) | 1 (8.3%) |
Previous Transplant | 100 (29.6%) | 3 (25.0%) | 0 (0.0%) |
PRA>80 at Transplant | 26 (7.7%) | 1 (8.3%) | 1 (8.3%) |
Fried Frailty | 48 (14.2%) | 2 (16.7%) | 1 (8.3%) |
Low Functional Status | 9 (2.7%) | 0 (0.0%) | 0 (0.0%) |
EPTS Score | 34.2 (13.5–57.3) | 10.5 (1.2–35.3) | 5.8 (1.1–17.0) |
Serum Albumin (g/dL) | 4.2 (3.9–4.6) | 4.6 (4.3–4.7) | 4.5 (4.0–4.9) |
Donor Characteristics | |||
Female | 211 (62.4%) | 7 (58.3%) | 8 (66.7% |
Black | 46 (13.6%) | 1 (8.3%) | 1 (8.3% |
Hispanic | 10 (3.0%) | 1 (8.3%) | 0 (0.0% |
Age | 46.0 (37.0–54.0) | 45.5 (39.5–51.0) | 49.0 (38.5–53.0) |
BMI | 26.6 (23.7–29.2) | 27.7 (25.5–29.1) | 24.0 (21.9–30.7) |
eGFR | 100.1 (85.2–113.4) | 106.0 (90.2–125.5) | 97.3 (82.8–108.1) |
Biologically Related | 122 (36.1%) | 7 (58.3%) | 5 (41.7% |
Transplant Characteristics | |||
ABO Incompatible | 43 (12.7%) | 1 (8.3%) | 1 (8.3%) |
Zero HLA mismatch | 21 (6.3%) | 1 (8.3%) | 0 (0.0%) |
Cold Ischemia Time | 1.5 (1.0–3.0) | 1.5 (1.0–2.0) | 1.5 (0.8–7.0) |
Antibody Depleting Induction | 283 (83.7%) | 9 (75.0%) | 11 (91.7%) |
Nonantibody Depleting Induction | 65 (19.2%) | 2 (16.7%) | 1 (8.3%) |
Characteristics are presented as percentages for binary variables and median (interquartile range) for continuous variables.